Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BIONOR IMMUNO AS
AS
Active
Org 982248108
Karenslyst Allé 6, 0278
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 25 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BIONOR IMMUNO AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
-2M
-3M
-5M
-6M
-5M
2020
-3M
+40%
2021
-5M
-67%
2022
0M
+100%
2023
0M
0%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
64
0
0
0
Staff expenses
−791
−15
−0
−6
270
EBITDA
−4 794
−2 590
−5 131
−460
−93
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−4 794
−2 590
−5 131
−460
−93
Net financials
−197
−15
0
0
−75
Profit before tax
−4 990
−2 605
−5 131
−460
−167
Tax
−0
−0
−0
−0
−0
Net profit
−4 990
−2 605
−5 131
−460
−167
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
451
292
371
151
138
Equity
−8 755
−11 360
−16 491
−16 951
−17 119
Long-term debt
5 059
5 059
0
79
0
Short-term debt
4 147
6 593
16 862
17 024
17 257
Total debt
9 206
11 653
16 862
17 103
17 257
Financial ratios
5-year trend
EBITDA margin
-9269500.0%
This company
15.8%
Market median
-58667822% vs market
2020
2024
Equity ratio
-12415.0%
This company
38.2%
Market median
-32600% vs market
2020
2024
Return on equity
-16742000.0%
This company
18.4%
Market median
-90989230% vs market
2020
2024
Net profit margin
-16742000.0%
This company
8.1%
Market median
-206691458% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on BIONOR IMMUNO AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
